Naltrexone: A Short-Term Treatment for Opiate Dependence
Robert A. Greenstein, Charles P. O’Brien, A. Thomas McLellan, George Woody, John Grabowski, Melody Long, Geraldine Coyle-Perkins, Anita Vittor
Abstract
Robert A. Greenstein, Charles P. O’Brien, A. Thomas McLellan, George Woody, John Grabowski, Melody Long, Geraldine Coyle-Perkins, Anita Vittor
Abstract
The narcotic antagonist, naltrexone, was studied in 242 patients during a 6-year period. Although a large number of subjects discontinued naltrexone abruptly, treatment was related to a significant decrease in opiate and nonopiate drug use. Methods for improving retention during induction and maintenance are discussed and posttreatment outcome results are presented. The authors conclude that naltrexone may be a useful short-term treatment option for opiate dependence.
OpenAlex reports 42 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The narcotic antagonist, naltrexone, was studied in 242 patients during a 6-year period. Although a large number of subjects discontinued naltrexone abruptly, treatment was related to a significant decrease in opiate and nonopiate drug use. Methods for improving retention during induction and maintenance are discussed and posttreatment outcome results are presented. The authors conclude that naltrexone may be a useful short-term treatment option for opiate dependence.
Key concepts: Naltrexone, Opiate, Narcotic antagonist, Narcotic antagonists, Antagonist, Medicine, Anesthesia, Narcotic